0001127602-17-016759.txt : 20170503 0001127602-17-016759.hdr.sgml : 20170503 20170503205850 ACCESSION NUMBER: 0001127602-17-016759 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170501 FILED AS OF DATE: 20170503 DATE AS OF CHANGE: 20170503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Piacquad David CENTRAL INDEX KEY: 0001602343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 17811458 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-05-01 0000318154 AMGEN INC AMGN 0001602343 Piacquad David ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 SVP, Business Development Common Stock 2017-05-01 4 A 0 984 0 A 33533 D Nqso (Right to Buy) 162.60 2017-05-01 4 A 0 8714 0 A 2019-05-01 2027-05-01 Common Stock 8714 8714 D The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. These shares include the following RSUs granted under the Company's equity plans: 397 RSUs which vest on 4/25/2018; 704 RSUs which vest in two installments of 347 and 357 on 1/30/2018 and 1/30/2019, respectively; 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively; and 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.mmon stock on a one-to-one basis. These shares include 92 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount. These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively. /s/ Andrea A. Robinson, Attorney-in-Fact for Mr. Piacquad 2017-05-03